Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| BK Virus | 4 | 2019 | 135 | 1.69 | Why? |
| Pancreas Transplantation | 2 | 2020 | 163 | 1.47 | Why? |
| Immunologic Memory | 6 | 2021 | 3362 | 1.25 | Why? |
| Kidney Transplantation | 9 | 2021 | 5397 | 1.10 | Why? |
| Polyomavirus Infections | 4 | 2019 | 156 | 1.05 | Why? |
| Weightlessness | 2 | 2018 | 12 | 0.97 | Why? |
| Immunity, Cellular | 6 | 2021 | 3614 | 0.88 | Why? |
| T-Lymphocytes | 6 | 2021 | 6670 | 0.86 | Why? |
| Immunity, Humoral | 5 | 2021 | 4849 | 0.85 | Why? |
| Monitoring, Immunologic | 1 | 2020 | 153 | 0.79 | Why? |
| Space Flight | 1 | 2018 | 37 | 0.74 | Why? |
| Aerospace Medicine | 1 | 2018 | 47 | 0.73 | Why? |
| Organ Transplantation | 4 | 2021 | 2616 | 0.71 | Why? |
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 203 | 0.70 | Why? |
| Meningoencephalitis | 1 | 2020 | 208 | 0.69 | Why? |
| CD4-Positive T-Lymphocytes | 5 | 2020 | 4545 | 0.68 | Why? |
| Viral Structural Proteins | 1 | 2020 | 491 | 0.64 | Why? |
| Herpesvirus 4, Human | 1 | 2018 | 387 | 0.57 | Why? |
| Graft Rejection | 3 | 2020 | 1766 | 0.56 | Why? |
| Virus Activation | 1 | 2019 | 480 | 0.54 | Why? |
| Cytomegalovirus | 2 | 2018 | 600 | 0.53 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2019 | 760 | 0.51 | Why? |
| Rituximab | 1 | 2021 | 1096 | 0.50 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2019 | 698 | 0.50 | Why? |
| Immunocompromised Host | 4 | 2021 | 5150 | 0.46 | Why? |
| Influenza Vaccines | 2 | 2019 | 2941 | 0.45 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.45 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.43 | Why? |
| Transplant Recipients | 3 | 2020 | 4982 | 0.40 | Why? |
| Tumor Virus Infections | 3 | 2019 | 127 | 0.39 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.35 | Why? |
| Cross Reactions | 1 | 2019 | 4374 | 0.34 | Why? |
| Influenza A virus | 1 | 2019 | 2234 | 0.32 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.30 | Why? |
| Influenza, Human | 2 | 2019 | 10779 | 0.25 | Why? |
| Postoperative Complications | 2 | 2020 | 5861 | 0.24 | Why? |
| Hepatitis A Virus Cellular Receptor 1 | 2 | 2018 | 86 | 0.22 | Why? |
| Calcineurin Inhibitors | 2 | 2018 | 218 | 0.21 | Why? |
| Lipocalin-2 | 2 | 2018 | 156 | 0.21 | Why? |
| B-Lymphocytes | 3 | 2021 | 4418 | 0.21 | Why? |
| Receptors, NK Cell Lectin-Like | 1 | 2019 | 9 | 0.20 | Why? |
| Hypergravity | 1 | 2018 | 5 | 0.20 | Why? |
| Leukocyte L1 Antigen Complex | 2 | 2018 | 238 | 0.20 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.19 | Why? |
| Regulatory Sequences, Nucleic Acid | 1 | 2019 | 95 | 0.19 | Why? |
| Nephrologists | 1 | 2020 | 117 | 0.19 | Why? |
| Kidney Glomerulus | 1 | 2020 | 144 | 0.19 | Why? |
| Cold Ischemia | 1 | 2018 | 37 | 0.19 | Why? |
| Microbial Interactions | 1 | 2018 | 67 | 0.18 | Why? |
| Isometric Contraction | 1 | 2017 | 19 | 0.18 | Why? |
| Kidney Tubular Necrosis, Acute | 1 | 2017 | 56 | 0.18 | Why? |
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2018 | 52 | 0.18 | Why? |
| T-Lymphocyte Subsets | 3 | 2020 | 1387 | 0.18 | Why? |
| Nephrotic Syndrome | 1 | 2020 | 146 | 0.18 | Why? |
| Adult | 21 | 2021 | 244371 | 0.18 | Why? |
| Kidney Diseases | 2 | 2020 | 1434 | 0.18 | Why? |
| Male | 27 | 2021 | 367725 | 0.17 | Why? |
| ADP-ribosyl Cyclase 1 | 1 | 2017 | 96 | 0.17 | Why? |
| Granulocytes | 1 | 2018 | 140 | 0.17 | Why? |
| Transplantation, Homologous | 1 | 2020 | 757 | 0.17 | Why? |
| Lymphoproliferative Disorders | 1 | 2018 | 110 | 0.17 | Why? |
| Vascular Stiffness | 2 | 2018 | 264 | 0.17 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.17 | Why? |
| Ki-67 Antigen | 1 | 2017 | 139 | 0.17 | Why? |
| Glomerulonephritis, IGA | 1 | 2018 | 115 | 0.16 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.16 | Why? |
| Hand Strength | 1 | 2017 | 202 | 0.16 | Why? |
| Purpura, Thrombotic Thrombocytopenic | 1 | 2021 | 284 | 0.16 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.16 | Why? |
| Herpesviridae Infections | 1 | 2018 | 172 | 0.16 | Why? |
| Humans | 40 | 2021 | 930598 | 0.16 | Why? |
| Hyperuricemia | 1 | 2017 | 160 | 0.16 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 552 | 0.16 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.15 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.15 | Why? |
| Receptors, G-Protein-Coupled | 1 | 2019 | 309 | 0.15 | Why? |
| Aorta | 1 | 2018 | 355 | 0.15 | Why? |
| Graft Survival | 1 | 2018 | 587 | 0.15 | Why? |
| Immunologic Tests | 1 | 2018 | 445 | 0.15 | Why? |
| Renal Dialysis | 3 | 2021 | 4358 | 0.15 | Why? |
| Female | 24 | 2021 | 380317 | 0.14 | Why? |
| von Willebrand Factor | 1 | 2021 | 668 | 0.14 | Why? |
| Dried Blood Spot Testing | 1 | 2018 | 383 | 0.14 | Why? |
| Cyclosporine | 1 | 2018 | 449 | 0.14 | Why? |
| Aged | 15 | 2021 | 215776 | 0.14 | Why? |
| Uric Acid | 1 | 2017 | 285 | 0.13 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.13 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.13 | Why? |
| Transcription, Genetic | 1 | 2019 | 1326 | 0.12 | Why? |
| Germany | 4 | 2021 | 9196 | 0.12 | Why? |
| Kinetics | 2 | 2018 | 3238 | 0.12 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.12 | Why? |
| Epigenesis, Genetic | 1 | 2018 | 711 | 0.12 | Why? |
| Immunosuppressive Agents | 3 | 2018 | 6331 | 0.11 | Why? |
| Cytomegalovirus Infections | 1 | 2018 | 667 | 0.11 | Why? |
| Membrane Glycoproteins | 1 | 2020 | 2273 | 0.11 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.10 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.10 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.09 | Why? |
| Transforming Growth Factor beta1 | 1 | 2010 | 204 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Exercise Therapy | 1 | 2017 | 976 | 0.09 | Why? |
| Severe Dengue | 1 | 2010 | 135 | 0.09 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.09 | Why? |
| Genetic Predisposition to Disease | 2 | 2021 | 4027 | 0.09 | Why? |
| Killer Cells, Natural | 1 | 2018 | 2093 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.08 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.08 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.08 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.08 | Why? |
| Hypertension | 2 | 2017 | 8895 | 0.08 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Liver Diseases | 1 | 2019 | 2698 | 0.06 | Why? |
| Interleukin-10 | 1 | 2010 | 1409 | 0.06 | Why? |
| Dengue Virus | 1 | 2010 | 910 | 0.06 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.06 | Why? |
| Multicenter Studies as Topic | 2 | 2020 | 2437 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.05 | Why? |
| Cytotoxins | 1 | 2020 | 57 | 0.05 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Viral Load | 2 | 2018 | 15850 | 0.05 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2010 | 2483 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Sulfites | 1 | 2018 | 9 | 0.05 | Why? |
| Recurrence | 2 | 2020 | 3675 | 0.05 | Why? |
| Luminescent Proteins | 1 | 2019 | 142 | 0.05 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.05 | Why? |
| Insulin-Like Growth Factor Binding Proteins | 1 | 2018 | 35 | 0.05 | Why? |
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2018 | 45 | 0.05 | Why? |
| Methods | 1 | 2017 | 19 | 0.05 | Why? |
| Antimetabolites | 1 | 2018 | 106 | 0.05 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.04 | Why? |
| Cell Count | 1 | 2018 | 228 | 0.04 | Why? |
| Vascular Resistance | 1 | 2018 | 148 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2021 | 867 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Furosemide | 1 | 2017 | 99 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2018 | 325 | 0.04 | Why? |
| Genetic Loci | 1 | 2018 | 439 | 0.04 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Pulse Wave Analysis | 1 | 2017 | 221 | 0.04 | Why? |
| Radial Artery | 1 | 2017 | 132 | 0.04 | Why? |
| Blood Pressure | 2 | 2017 | 2198 | 0.04 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.04 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.04 | Why? |
| Neonatal Screening | 1 | 2018 | 285 | 0.04 | Why? |
| Antigens, CD | 1 | 2020 | 984 | 0.04 | Why? |
| Genotype | 2 | 2021 | 4697 | 0.04 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.04 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.03 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.03 | Why? |
| DNA Methylation | 1 | 2018 | 688 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Biopsy | 1 | 2020 | 2811 | 0.03 | Why? |
| Time Factors | 3 | 2018 | 31397 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2020 | 53120 | 0.03 | Why? |
| Flow Cytometry | 1 | 2019 | 2393 | 0.03 | Why? |
| General Practitioners | 1 | 2017 | 568 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2021 | 3607 | 0.02 | Why? |
| Acute Kidney Injury | 2 | 2018 | 5762 | 0.02 | Why? |
| Genetic Association Studies | 1 | 2010 | 559 | 0.02 | Why? |
| Haplotypes | 1 | 2010 | 853 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Disease Progression | 2 | 2018 | 13580 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| HEK293 Cells | 1 | 2019 | 8394 | 0.02 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.02 | Why? |
| Liver | 1 | 2019 | 4007 | 0.02 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.02 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.02 | Why? |
| Polymorphism, Genetic | 1 | 2010 | 1074 | 0.02 | Why? |
| Shock | 1 | 2010 | 1868 | 0.02 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.02 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Retrospective Studies | 2 | 2018 | 105322 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2010 | 9537 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.01 | Why? |
| Antiviral Agents | 1 | 2019 | 41703 | 0.00 | Why? |
Babel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(204)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(153)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_